Onassis Holdings Corp

PINK:ONSS USA Drug Manufacturers - Specialty & Generic
Market Cap
$98.01
Market Cap Rank
#50111 Global
#15295 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.01
All Time High
$0.35
About

Onassis Holdings Corp. focuses on the wellness, cannabidiol (CBD) and hemp oil, and cosmetics industries. The company provides various products and services to businesses operating in the CBD and hemp oil industry in the United States and Europe. It also develops and markets electronic disinfection devices. The company was formerly known as Onassis Mining Group, Inc. and changed its name to Onass… Read more

Onassis Holdings Corp (ONSS) - Net Assets

Latest net assets as of June 2024: $-2.40 Million USD

Based on the latest financial reports, Onassis Holdings Corp (ONSS) has net assets worth $-2.40 Million USD as of June 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($939.64K) and total liabilities ($3.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-2.40 Million
% of Total Assets -255.46%
Annual Growth Rate N/A
5-Year Change -10680.45%
10-Year Change -102.36%
Growth Volatility 1864.04

Onassis Holdings Corp - Net Assets Trend (2008–2023)

This chart illustrates how Onassis Holdings Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Onassis Holdings Corp (2008–2023)

The table below shows the annual net assets of Onassis Holdings Corp from 2008 to 2023.

Year Net Assets Change
2023-12-31 $-284.08K -319.40%
2022-12-31 $-67.74K +88.27%
2021-12-31 $-577.27K -310.00%
2020-12-31 $-140.80K -5343.91%
2019-12-31 $2.69K -99.98%
2013-12-31 $11.33 Million -12.82%
2012-12-31 $12.99 Million +7.48%
2011-12-31 $12.09 Million +7.22%
2010-12-31 $11.28 Million -6.23%
2009-12-31 $12.02 Million -3.00%
2008-12-31 $12.40 Million --

Equity Component Analysis

This analysis shows how different components contribute to Onassis Holdings Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1419257900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Common Stock $127.91K %
Other Comprehensive Income $-127.91K %
Other Components $14.01 Million %
Total Equity $-284.08K 100.00%

Onassis Holdings Corp Competitors by Market Cap

The table below lists competitors of Onassis Holdings Corp ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Onassis Holdings Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from -67,736 to -284,085, a change of -216,349.
  • Net loss of 216,000 reduced equity.
  • Other factors decreased equity by 349.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income $-216.00K -76.03%
Other Changes $-349.00 -0.12%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Onassis Holdings Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 $-0.01 $0.01 x
2005-12-31 $-0.02 $0.01 x
2006-12-31 $-1.67 $0.01 x
2007-12-31 $-0.03 $0.01 x
2008-12-31 $15.14 $0.01 x
2009-12-31 $14.45 $0.01 x
2010-12-31 $10.03 $0.01 x
2011-12-31 $7.48 $0.01 x
2012-12-31 $0.91 $0.01 x
2013-12-31 $0.53 $0.01 x
2019-12-31 $0.00 $0.01 x
2020-12-31 $0.00 $0.01 x
2021-12-31 $0.00 $0.01 x
2022-12-31 $0.00 $0.01 x
2023-12-31 $0.00 $0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Onassis Holdings Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-239.71%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 0.00% 0.00% 0.00x 0.00x $-42.55K
2005 0.00% 0.00% 0.00x 0.00x $-15.40K
2006 0.00% 0.00% 0.00x 0.00x $-6.65K
2007 0.00% 0.00% 0.00x 0.00x $-10.35K
2008 2.14% 6.95% 0.29x 1.06x $-974.40K
2009 1.64% 2.38% 0.35x 1.98x $-1.01 Million
2010 -4.78% -4.41% 0.42x 2.56x $-1.67 Million
2011 11.39% 9.31% 0.77x 1.59x $167.98K
2012 6.97% 5.71% 0.86x 1.42x $-393.46K
2013 8.74% 5.39% 0.99x 1.63x $-142.57K
2019 -3621.75% 0.00% 0.00x 39.31x $-97.51K
2020 0.00% -676.05% 0.55x 0.00x $-286.40K
2021 0.00% -844.65% 0.28x 0.00x $-393.27K
2022 0.00% -2804.43% 0.01x 0.00x $-183.23K
2023 0.00% 0.00% 0.00x 0.00x $-187.59K

Industry Comparison

This section compares Onassis Holdings Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Onassis Holdings Corp (ONSS) $-2.40 Million 0.00% N/A $99.32
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million